Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy
- PMID: 16956712
- DOI: 10.1016/j.eururo.2006.08.008
Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy
Abstract
Objectives: To evaluate CpG island hypermethylation in a set of candidate genes in prostate cancer (pCA) and its relationship to clinicopathologic parameters and a nomogram predicting prostate-specific antigen (PSA) recurrence after radical prostatectomy.
Materials and methods: Tissues of 78 prostate carcinomas, 32 benign prostate hyperplasias (BPHs), and prostate cell lines (LNCaP, DU145, PC3, BPH-1) were examined with MethyLight polymerase chain reaction at 13 gene loci (APC, CDC6, CTNNB1, E-Cadherin, EDNRB, FGFR2, GSTP1, NAB2, PKCmu, PTGS2, RAR-beta, RASL11A, WWOX).
Results: APC, RAR-beta, PTGS2, GSTP1, EDNRB, and CTNNB1 (83%, 71%, 65%, 33%, 14%, 9%, respectively) were methylated in pCA but rarely or not methylated in BPH. NAB2 and CDC6 were hypermethylated frequently in pCA (92%, 67%, respectively) and in BPH (91%, 59%, respectively). FGFR2, WWOX, E-Cadherin, PKCmu, and RASLL1A did not display noteworthy methylation in pCA (0-1%) or in BPH. CpG island hypermethylation at APC, retinoic acid receptor beta (RAR-beta), and PTGS2 discriminated with a sensitivity of 65-83% and a specificity of 97-100% between BPH and pCA. The combination of various genes increased the diagnostic expressiveness. PTGS2 hypermethylation correlated with seminal vesicle infiltration (p=0.047), capsular penetration (p=0.004), and pT stage (p=0.014). RAR-beta methylation was accompanied by a higher cumulative Gleason score (p=0.042). The probability of PSA-free-survival calculated with a Kattan nomogram correlated inversely with CpG island hypermethylation at EDNRB, RAR-beta, and PTGS2. All prostate cancer cell lines displayed a varying degree of demethylation after 5-aza-2'deoxycytidine treatment.
Conclusions: CpG island hypermethylation at various gene loci is frequent in prostate cancer and can distinguish between neoplastic and noncancerous tissue. Furthermore, hypermethylation at PTGS2, RAR-beta, and EDNRB inversely correlated with PSA-free-survival according to a Kattan nomogram and has potential prognostic value.
Similar articles
-
CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.Urology. 2008 Jan;71(1):161-7. doi: 10.1016/j.urology.2007.09.056. Urology. 2008. PMID: 18242387
-
Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.Clin Cancer Res. 2005 Jun 1;11(11):4097-106. doi: 10.1158/1078-0432.CCR-04-1832. Clin Cancer Res. 2005. PMID: 15930345
-
CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.Prostate. 2008 Jan 1;68(1):42-9. doi: 10.1002/pros.20651. Prostate. 2008. PMID: 18004747
-
GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.J Cell Biochem. 2004 Feb 15;91(3):540-52. doi: 10.1002/jcb.10740. J Cell Biochem. 2004. PMID: 14755684 Review.
-
Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.Eur Urol. 2004 Dec;46(6):698-708. doi: 10.1016/j.eururo.2004.07.022. Eur Urol. 2004. PMID: 15548435 Review.
Cited by
-
Effects of Inflammation on the Immune Microenvironment in Gastric Cancer.Front Oncol. 2021 Jul 23;11:690298. doi: 10.3389/fonc.2021.690298. eCollection 2021. Front Oncol. 2021. PMID: 34367971 Free PMC article.
-
Hypermethylation of genes for diagnosis and risk stratification of prostate cancer.Cancer Invest. 2009 Jun;27(5):549-60. doi: 10.1080/07357900802620794. Cancer Invest. 2009. PMID: 19229700 Free PMC article.
-
Promoter hypermethylation in prostate cancer.Cancer Control. 2010 Oct;17(4):245-55. doi: 10.1177/107327481001700405. Cancer Control. 2010. PMID: 20861812 Free PMC article. Review.
-
DNA methylation changes in prostate cancer: current developments and future clinical implementation.Expert Rev Mol Diagn. 2009 Apr;9(3):243-57. doi: 10.1586/erm.09.10. Expert Rev Mol Diagn. 2009. PMID: 19379083 Free PMC article. Review.
-
Prognostic Value of Promoter Hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in Prostate Cancer.Chin J Cancer Res. 2011 Dec;23(4):306-11. doi: 10.1007/s11670-011-0306-x. Chin J Cancer Res. 2011. PMID: 23358881 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous